These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Study of the tumor cell-lymphocyte interaction in patients with breast cancer. Deodhar SD; Crile G; Esselstyn CB Cancer; 1972 May; 29(5):1321-5. PubMed ID: 4336633 [No Abstract] [Full Text] [Related]
5. DNCB sensitivity in cancer patients. A review based on sequential testing in 430 patients. Bolton PM Clin Oncol; 1975 Mar; 1(1):59-69. PubMed ID: 1106933 [No Abstract] [Full Text] [Related]
6. [The determination of receptors for estradiol in breast carcinomas and the possibilities of endocrine therapy]. Aimone V; Campagnoli C; Fumero S; Perona M; Zanolo G Minerva Ginecol; 1975 Jul; 27(7):493-504. PubMed ID: 174031 [No Abstract] [Full Text] [Related]
7. Antigen solubilized from human solid tumours: lymphocyte stimulation and cutaneous delayed hypersensitivity. Mavligit GM; Ambus U; Gutterman JU; Hersh EM; McBride CM Nat New Biol; 1973 Jun; 243(127):188-90. PubMed ID: 4514633 [No Abstract] [Full Text] [Related]
8. A correlation of DNCB-induced delayed cutaneous hypersensitivity reactions and the course of disease in patients with recurrent breast cancer. Cunningham TJ; Daut D; Wolfgang PE; Mellyn M; Maciolek S; Sponzo RW; Horton J Cancer; 1976 Apr; 37(4):1696-1700. PubMed ID: 1260685 [TBL] [Abstract][Full Text] [Related]
9. Prediction of breast cancer response to endocrine therapy. DeSombre ER; Smith S; Block GE; Ferguson DJ; Jensen EV Cancer Chemother Rep; 1974; 58(4):513-9. PubMed ID: 4369030 [No Abstract] [Full Text] [Related]
10. [State of immunological reactivity in breast cancer patients receiving prednisolone treatment]. Tsyrlina EV; Fedorov SN; Poroshina TE; Buslaeva VP; Seleznev IK Vopr Onkol; 1979; 25(5):60-2. PubMed ID: 462856 [No Abstract] [Full Text] [Related]
11. A correlation of in vivo delayed-type hypersensitivity with in vitro lymphocyte transformation in sarccidosis. Sharma OP; James DG; Fox RA Chest; 1971 Jul; 60(1):35-7. PubMed ID: 5571271 [No Abstract] [Full Text] [Related]
12. Adrenalectomy and oophorectomy plus limited-term chemotherapy in the treatment of breast cancer. Hoge AF; Bottomley RH; Shaw MT; Asal NR Cancer Treat Rep; 1976 Jul; 60(7):857-65. PubMed ID: 1009519 [TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immune status of breast cancer patients: evaluation by skin tests, lymphocyte stimulation, and counts of rosette-forming cells. Nemoto T; Han T; Minowada J; Angkur V; Chamberlain A; Dao L J Natl Cancer Inst; 1974 Sep; 53(3):641-5. PubMed ID: 4606319 [No Abstract] [Full Text] [Related]
15. In vitro observations on sarcoid lymphocytes and their correlation with cutaneous energy and clinical severity of disease. Kataria YP; Sagone AL; LoBuglio AG; Bromberg PA Am Rev Respir Dis; 1973 Oct; 108(4):767-76. PubMed ID: 4741873 [No Abstract] [Full Text] [Related]
16. Prognostic significance of oestrogen uptake by human breast-cancer tissue. Braunsberg H; James VH; Irvine WT; Jamieson CW; James F; Sellwood RA; Carter AE; Hulbert M Lancet; 1973 Jan; 1(7796):163-5. PubMed ID: 4118790 [No Abstract] [Full Text] [Related]
17. Sarcoidosis: correlation of delayed hypersensitivity, MLC reactivity and lymphocytotoxicity with disease activity. Broom BC; MacLaurin BP Clin Exp Immunol; 1973 Nov; 15(3):355-64. PubMed ID: 4271772 [TBL] [Abstract][Full Text] [Related]
18. [Estrogen receptors in breast cancers and endocrine therapy]. Maass H; Trams G; Nowakowski H Strahlentherapie; 1974 Apr; 147(4):381-7. PubMed ID: 4369557 [No Abstract] [Full Text] [Related]
19. Immunosuppression in children with malaria. Greenwood BM; Bradley-Moore AM; Bryceson AD; Palit A Lancet; 1972 Jan; 1(7743):169-72. PubMed ID: 4109547 [No Abstract] [Full Text] [Related]